(1) Creatine kinase determination in malignant hyperpyrexia: Creatine kinase determination in serum may be used to aid the detection of susceptibility to malignant hyperpyrexia. This condition, which is a rare complication of general anesthetic administration, frequently shows an autosomal dominant pattern of inheritance. Family members at risk may show serum creatine kinase elevation, although clinically normal (Isaacs & Barlow 1970 , Denborough et al. 1970 . Such elevation may be used to trace the inheritance pattern of the disorder.
(2) Serum cholinesterase determination in succinylcholine apnoea: Low plasma cholinesterase levels of genetic origin may result in susceptibility to the muscle relaxant succinylcholine, and prolonged apneea following its administration. At least ten cholinesterase genotypes may be identified by measurement of serum cholinesterase activity and the effects of the inhibitors fluoride and dibucaine (Harris 1964) . The common genotype contains two 'usual' cholinesterase genes. When the serum cholinesterase genotype lacks the 'usual gene' susceptibility to succinylcholine results.
Identification of the carrier state of genetically determined disease: Again, two examples are chosen:
(1) Creatine kinase in the identification of female carriers of Duchenne dystrophy: Duchenne muscular dystrophy is a sex-linked condition, which is carried by apparently healthy females who transmit the disease to half their sons and the carrier state to half their daughters. Eighty per cent of female carriers may be identified by the finding of raised serum creatine kinase levels (e.g. Dreyfus, Schapira & Demos 1960). (2) Identification of heterozygote carriers of Tay-Sachs disease: Tay-Sachs disease is inherited as an autosomal recessive. The heterozygous carrier state in males and females is particularly high in Jews, where it may exceed a level of 1 in 40. Since there is a 1 in 4 chance of the child of two carriers developing and dying from the disease, the identification of the carrier state is vital in such highrisk populations. This can be done by the demonstration of lowered levels of serum hexosaminidase-A activity in carriers (O'Brien et al. 1970) . Detection of unsuspected disease by population screening: Enzyme determinations are commonly included in population screening profiles, the enzymes most frequently used for this purpose being aspartate transaminase, alkaline phosphatase and lactate dehydrogenase. Using aspartate transaminase as an example, results obtained in studies of hospital admission (Whitehead & Carmalt 1969 ) and on general practitioner outpatients (Carmalt et al. 1970 ) reveal a total incidence of abnormality of between 2 % and 4 %. The incidence of unexpected abnormality in tests not normally requested falls to 1-2%, and in threequarters of these patients the elevation remains unexplained on follow-up. Where unsuspected disease is revealed as a result of aspartate transaminase determination, this is generally hepatic in nature. (1) Creatine kinase determination for the preclinical diagnosis of Duchenne muscular dystrophy: Duchenne muscular dystrophy is not usually manifest clinically before the second year of life. However, dramatic elevation of serum creatine kinase levels permits preclinical diagnosis or exclusion of the disorder within a few months of birth (Aebi et al. 1961 ).
(2) Serum cholinesterase determination for the presymptomatic diagnosis of insecticide toxicity: Presymptomatic evidence of excessive exposure to organophosphorus insecticides is provided by the finding of lowered serum cholinesterase levels (Namba et al. 1971 ). This use is well-known to those working in occupational medicine.
(3) Transaminase determination in viral hepatitis: Transaminase elevation in serum may be helpful in identifying viral hepatitis at a pre-jaundice, preclinical or subclinical stage, since elevation may precede by days or weeks clinical evidence of the disorder. Transaminase elevation has been used for identification of such cases in outbreaks of hepatitis in closed or semi-closed communities, such as on ship or in schools (Wroblewski & La Due 1956a , Goldberg & Campbell 1962 . The determination may thus be of epidemiological importance.
(4) y-Glutamyl transpeptidase determination in alcoholism: Alcoholism appears to be widespread and of increasing incidence. It is of concern to those working in occupational medicine. Serum y-glutamyl transpeptidase (GGTP) elevation provides a useful screening test for alcoholism and heavy drinking. The enzyme is elevated in some 70 % of such patients, even in the absence of other clinical or biochemical evidence of hepatic involvement (Rosalki & Rau 1972) . Such elevation is thought to be largely a consequence of induction of the enzyme in the liver following long standing alcohol administration. Organ-localization of disease: differential diagnosis: An additional major use of enzyme tests is the organ-localization of disease for purposes of differential diagnosis. For example, in the differentiation of possible myocardial or hepatic origin of lower chest pain, alanine transaminase determination may be helpful, since this enzyme is frequently elevated in liver disorders, but remains at normal or near normal levels in the early stages following myocardial infarction (Wroblewski & La Due 1956b). Another example is the creatine kinase elevation which may occur in myopathic muscle disease, in contrast to normal serum values for this enzyme which are usual in muscle disease secondary to nerve involvement (Okinaka et al. 1961) . As an aid to the organ localization of disease, where an enzyme may originate from more than one tissue, it may frequently be helpful to separate that enzyme into constituent isoenzyme forms. Lactate dehydrogenase (LD) isoenzyme separation of serum is a familiar example. The serum enzyme may be separated electrophoretically into five isoenzymes of which those of intermediate electrophoretic mobility are normally the most prominent. Heart tissue, however, contains the most anodically migrating isoenzyme, LD1, and after myocardial infarction it is this fraction which is elevated in the serum. In contrast, liver contains mainly the most cathodically migrating fraction, LD5, and in hepatitis it is this serum LD fraction which is found to be raised (Wieme 1959 , Wroblewski et al. 1960 .
Characterization of organ pathology: Enzyme tests may be used not only to localize the site of organ pathology, but to characterize this. For example, in the liver, aspartate transaminase is present in the cell sap and in the mitochondria, differing isoenzyme forms being present in each cellular compartment. Minor hepatic damage will liberate the cytoplasmic isoenzyme into the serum but little mitochondrial isoenzyme, more severe damage with mitochondrial injury will liberate substantial amounts of the mitochondrial isoenzyme (Ideo et al. 1972) .
Detection of the action of toxic agents: Enzyme tests are commonly used to detect the effects of toxic agents and the site, severity and nature of these. For example, transaminase and alkaline phosphatase determination are particularly useful for the detection of hepatotoxicity. The former is especially elevated from drugs giving rise to hepatitic toxic change (Wroblewski 1959) , and the latter from drugs causing cholestasis (Gutman 1959) . Mention has already been made of the lowered serum cholinesterase values in patients exposed to organophosphorus insecticides.
Detection ofmalignant disease: Enzyme tests may be used to detect malignancy, either by the identification of organ damage as a result of infiltration of that organ by the malignant tissue, or by measurement of enzymes produced by the tumour tissue. Aspartate transaminase and alkaline phosphatase elevation as a result of liver metastases, and alkaline phosphatase elevation as a result of bone metastases are familiar examples of enzymes used for detecting neoplastic infiltration. Acid phosphatase elevation in serum consequent upon its production by malignant prostatic tissue is also widely known. However, it should be noted that malignant tissue may also liberate into the serum so-called 'tumourspecific' enzymes which are not normally present in the serum, but are produced by the tumour. Examples are serum histaminase elevation, which may be produced by medullary thyroid carcinoma (Baylin et al. 1972) , and an abnormal serum alkaline phosphatase, known as the Regan phosphatase which has enzyme characteristics similar to the alkaline phosphatase of normal human placenta, and which is elevated in the serum in some 5 % of patients with various carcinomas (Stolbach et al. 1969 ).
Assessment of therapeutic response: Reversion of abnormal serum enzyme levels to normal values, as a result of therapy, may be used to assess response to treatment. Serial serum alkaline phosphatase determinations to monitor the vitamin D treatment of rickets (Bodansky & Jaffe 1934 ) and serial serum creatine kinase determination to assess response to steroid therapy of polymyositis (Vignos & Goldwyn 1972 ) are instances of this use.
A ssessment of disease prognosis: Finally, enzyme tests may be used to assess prognosis. An example of this use is to be found in the relationship between the peak height of serum transaminase or lactate dehydrogenase activity following myocardial infarction, and early and late mortality from this disorder (Rosalki 1963 , Kibe & Nilsson 1967 . Higher mortality rates are found in association with grossly elevated serum enzyme levels. Another example is the use of creatine kinase in the determination and the assessment of the rapidity of progression of Duchenne muscular dystrophy; profound elevation in the early stages of the disease may signify a tendency for disorder to progress rapidly (Dreyfus et al. 1958 ).
Limitations ofEnzyme Tests
Enzyme tests are useful only if their limitations are known.
Limitations imposed by the state of the patient: In order to decide whether or not an enzyme result is abnormal, full information must be avilable on the state of the patient from whom the sample originated. Genetic status should be known: normal values for alkaline phosphatase are higher in patients of blood groups 0 and B (Arfors et al. 1963 ). The patient's race should be known: for example, creatine kinase is higher in Negroes than in Caucasians (Meltzer 1971) . The patient's age must also be known: high alkaline phosphatase values of bone origin in childhood as a consequence of rapid bone growth is a well-known observation (Clark & Beck 1950) .
The sex of the patient must be known, since for many serum enzymes there is a marked sex difference in normal values. Creatine kinase and y-glutamyl transpeptidase, for example, being higher in males than in females (Rosalki 1967 , Rosalki et al. 1970 . Information must also always be available on any condition such as pregnancy which may interfere with normal values. In late pregnancy, for example, a significant amount of alkaline phosphatase of placental origin appears in the serum (McMaster et al. 1964) .
Some enzymes such as the LD5 isoenzyme of lactate dehydrogenase show circadian variation (Starkweather, Spencer, Schwarz & Schoch 1966) , possibly in response to changes in dietary or exercise status. Postprandial elevation of intestinal alkaline phosphatase is an example of an enzyme whose serum level may alter as a result of food ingestion (Langman et al. 1966) . Lipamia may create technical difficulties in sample examination.
Many enzymes may be elevated following severe prolonged exercise and creatine kinase is particularly susceptible to such elevation (Baumann et al. 1962) . The patients' exercise-status prior to sampling is therefore relevant. Finally, accurate information must be available on any treatment or drug therapy which may result in serum enzyme changes. Such changes may be from organ toxicity or may be independent of toxic change. Thus, anticonvulsant drugs used for the treatment of epilepsy may give rise to serum y-glutamyl transpeptidase elevation from hepatic induction of the enzyme (Rosalki et al. 1971) . Intramuscular injections may result in elevation of serum enzymes of muscular origin (in particular creatine kinase) as a result of direct trauma to muscle (Hess et al. 1964) .
Limitations imposed by the condition ofthe sample: Improper sample handling may limit the value of enzyme test results. Venous stasis must be avoided in sample collection, for it may result in spurious enzyme elevation, for example of the LD6 isoenzyme (Starkweather, Green, Spencer & Schoch 1966) . Haemolysis must also be avoided, since liberation of red cell enzymes may spuriously elevate the level of many of the enzymes whose level in serum we may wish to measure. Thus, hxemolysis may give rise to serum lactate dehydrogenase elevation which is of red cell origin (Wroblewski & La Due 1955) , the LD1 isoenzyme being particularly elevated. Some anticoagulants normally used in plasma collection may act as enzyme inhibitors and must be avoided; examples are oxalate, which is an inhibitor of lactate dehydrogenase (Wroblewski & La Due 1955) , and sequestrene (EDTA), which inhibits serum alkaline phosphatase (Bowers & McComb 1966) .
Even a suitably collected sample must be examined fresh, or within the limit of storage stability of the enzyme under study, and the sample must of course be stored under suitable conditions prior to enzyme examination. Thus, whereas for most enzymes, serum is best stored frozen, the LD5 isoenzyme is very labile under these conditions (Kreutzer & Fennis 1964) . Similarly, whereas most enzymes of clinical importance are little altered in serum stored for up to 24 hours at room temperature (about 20°C) or 5 days at 4CC, the acid phosphatase of serum may fall substantially, unless the pH of the sample is artificially lowered (Richterich 1965 ).
Technical limitations: There are limitations in the use of enzyme tests which are best described as technical or methodological. Some test procedures may be complex, tedious or timeconsuming. In all enzyme test procedures scrupulous care must be taken in their performance for accurate and reproducible results. Reaction conditions of temperature and pH must be narrowly controlled; substrates and reagents must be of high purity.
Enzymological limitations: There are also limitations on enzyme tests which may be described as 'enzymological', in that despite the high activity of an enzyme in a particular organ, injury to that organ does not result in elevation of that enzyme in the serum. There may be many explanations for this, one of the commonest being lability of the enzyme in the serum. For example, isocitrate dehydrogenase is so rapidly destroyed within the circulation that, although it is abundant in heart tissue, its serum level is not elevated following myocardial infarction (Strandjord et al. 1959) .
Interpretive limitations: Finally there are limitations on the use of enzyme tests which may be described as 'interpretive'. These arise because the majority of serum enzymes may originate from more than one tissue. Thus, when serum enzyme elevation is observed, all these tissues must be considered as a potential source for the elevation. Assistance in interpretation may be obtained from knowledge of the clinical state; it may also be obtained by measurement of more than one enzyme and observations of patterns of enzyme change, a procedure sometimes known as 'enzyme organ profiling'. Rosalki S B & Rau D (1972) This paper gives an account of early experiences in carrying out enzyme profiles on company employees.
Aim ofthe Examinations
Sir Arthur Garrod in 1902 first suggested that no two individuals of a species are identical in their chemical processes (G Z Williams 1962). Later R J Williams (1956) indicated that a distinctive pattern of serum enzyme levels was characteristic of each individual and more recently the possibility has been suggested than an 'enzyme profile' of an individual may be as distinctive as his finger-prints or blood group (Simpson 1968) .
Frajola et al. (1960) showed this individuality to be a fact from their examination of sera from 7 pairs of identical twins, their siblings and parents, and from about 50 other healthy individuals. They also showed that just as each person has his own characteristic metabolic pattern, identifiable and recognizable by the activities of a particular set of enzymes, so also do people exhibit characteristic metabolic patterns in response to differently acting toxic substances. Biochemical profiles have been described of poisonings from trichloroethylene, benzene, phosphorous, carbon monoxide, decaborane, carbon tetrachloride, quinidine and iproniazid amongst others (Stokinger 1962).
The primary aim in this study was to determine the 'normal' enzyme profile of each person undergoing medical examination, for future reference.
Scope ofthe Examinations
Two particular groups of people seemed worthy of study: (1) Chemical workers undergoing periodical medical examinations (PMEs). (2) Participants in the Heart Disease Prevention Project (HDPP) directed by Professor Geoffrey Rose. These were men who were in the age group 40-59 years when the project started in 1971. Since atherosclerosis is a progressive disease, it seemed possible that changes due to arterial disease might be detected before clinical symptoms or signs appeared.
In addition to these two main groups there were patients, i.e. persons reporting with *some complaint and persons returning to work after long-term sickness absence. Another group cor,sisted of people taking part in volunteer trials involving the company's products. The responsibility of the Health Department, as far as volunteer trials on company employees is concerned, is to ensure that there is no contraindication on medical grounds to their taking part. Also included as a group were a few new employees and persons undergoing examination in connexion with extension of their employment beyond normal retirement age.
Choice ofEnzymes
In toxicology, in order to ascertain the possible target organs involved in a toxic process, a whole battery of serum enzymes is measured (Food and Cosmetic Toxicology 1970). The assumption is that the greater the number of enzyme activities determined the greater are the chances of detecting metabolic disturbances (Stokinger 1962) .
The choice of enzymes used in this study was decided upon by searching the literature for similar studies and by the scope of laboratory facilities. The enzymes which were examined routinely are listed in Table 1 , which also gives their normal ranges. Table I   Enzymes 
